Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Here’s What Happened
by Amy Steele · The Cerbat GemVoyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during mid-day trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Trading Up 47.4 %
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a market cap of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The firm has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Market Cap Calculator: How to Calculate Market Cap
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Stock Sentiment Analysis: How it Works
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year